Back to Insights
Bullish Swing Idea

20-Week Breakout Analysis — 2026-02-13

February 13, 2026 4 min read
Tickers Mentioned
FRMIOSCXNBIGORCXEVMN
Key Takeaways
  • FRMI: ATR multiple -0.70, 0 funds | OSCX: ATR multiple -1.87, 0 funds | NBIG: ATR multiple -0.87, 0 funds

Overview

February 13, 2026 delivered 258 total 20-week breakout signals, with a bearish tilt as 137 stocks triggered downside breaks versus 121 bullish breakouts. This 53% bearish ratio suggests increased selling pressure across the broader market, warranting defensive positioning and selective risk management.

Quality concerns dominate today’s bullish signals. The top movers are heavily weighted toward leveraged ETFs and ETNs with zero institutional backing, extreme volatility profiles, and significant drawdowns from 52-week highs. Most tickers show negative ATR multiples, indicating pullbacks within their recent ranges rather than genuine momentum expansion. Only EVMN presents institutional-grade characteristics with strong relative positioning near 52-week highs.

Top 5 Bullish Picks

EVMN ($31.57) — Medical Biomed/Biotech

EVMN Daily Chart

This medical biotech stands alone as the highest-quality breakout in today’s scan. Trading just 4.9% below its 52-week high and up 127.4% from its low, EVMN demonstrates genuine bullish momentum with a positive ATR multiple of 3.87. Volume surged 170% above average at 1.36 million shares, confirming institutional accumulation despite the undefined fund count data.

Level Price Calculation
Current $31.57 Entry reference
Stop Loss $28.13 -1 ATR ($3.44)
Target 1 $35.01 +1 ATR
Target 2 $38.45 +2 ATR

Risk Assessment: The 14.8% ADR and 44.1% LOD risk ATR indicate elevated volatility typical of biotech IPOs (bucket_0_youth category). Position sizing should account for the $3.44 ATR swing potential.

GDXU ($347.25) — Materials ETF

This leveraged precious metals ETF posted the largest dollar breakout at $54.50 ATR, up 855.4% from its 52-week low. However, it remains 35.8% below its high and shows a near-neutral ATR multiple of -0.12. The extreme price appreciation suggests this is a momentum extension rather than a new trend initiation.

Level Price Calculation
Current $347.25 Entry reference
Stop Loss $292.75 -1 ATR ($54.50)
Target 1 $401.75 +1 ATR

Risk Assessment: The 15.7% ADR with only 1.4% LOD risk suggests tight risk control, but zero institutional ownership and leveraged exposure demand caution.

FGL ($18.00) — Energy Solar

Solar energy play FGL exploded with 27.7x relative volume (1.43 million shares) but exhibits concerning technical characteristics. The negative ATR multiple of -2.72 and 88.9% distance from 52-week highs indicate this is a dead-cat bounce rather than sustainable momentum. The 118.5% LOD risk ATR signals extreme downside vulnerability.

Level Price Calculation
Current $18.00 Entry reference
Stop Loss $13.62 -1 ATR ($4.38)
Target 1 $22.38 +1 ATR

Risk Assessment: The 23.3% ADR makes this suitable only for aggressive traders. Zero institutional support in a young IPO (bucket_0_youth) compounds risk.

FRMI ($10.29) — Alternative Energy

FRMI Daily Chart

Leading the percentage breakout list, FRMI shows 43.3% gains from its low but trades 72.2% below its high. The negative ATR multiple of -0.70 and above-average volume (1.6x) suggest short-covering or speculative rotation rather than fundamental strength. Zero institutional ownership is a red flag.

Level Price Calculation
Current $10.29 Entry reference
Stop Loss $9.30 -1 ATR ($0.99)
Target 1 $11.28 +1 ATR

Risk Assessment: The 9.8% ADR with 25.1% LOD risk offers manageable volatility, but lack of institutional validation limits upside conviction.

VRTL ($94.99) — Industrials ETF

This ETF shows spectacular 1,154.8% gains from its low and a robust +5.90 ATR multiple—the only other positive reading besides EVMN. However, below-average volume (0.6x relative volume) and 15.7% distance from highs raise questions about momentum sustainability.

Level Price Calculation
Current $94.99 Entry reference
Stop Loss $85.28 -1 ATR ($9.71)
Target 1 $104.70 +1 ATR

Risk Assessment: The 12.0% ADR is moderate, but light volume at only 61,039 shares limits liquidity for position management.

Bearish Alerts

The 137 bearish signals outnumber bullish breakouts, led by HTFL (Computer Software-Medical) with 148 institutional holders now exiting positions. The software company trades 49.9% below its 52-week high with a -2.36 ATR multiple and 2.5x relative volume on the breakdown, suggesting institutional distribution.

Multiple leveraged ETFs dominate the bearish list (AFRU, SMU, LABX, UPSX), all showing catastrophic drawdowns of 77-96% from highs. The concentration of ETF failures on both bullish and bearish lists indicates widespread leveraged product resets and volatility expansion rather than directional conviction.

Sector Theme

Energy and healthcare provide the only non-ETF opportunities today. Alternative energy (FRMI, FGL) shows speculative interest but lacks institutional validation. Medical biotech (EVMN) offers the singular high-conviction setup with positive momentum characteristics and proximity to new highs.

The prevalence of Finance-ETF/ETN classifications across both bullish and bearish lists reveals a market struggling with direction, forcing capital into leveraged instruments that amplify noise rather than signal genuine sector rotation.

Institutional Summary

Institutional participation is virtually absent from today’s bullish breakouts. ORCX holds minimal interest with just 1 fund at 99% ownership. HTFL leads bearish exits with 148 funds, signaling smart money is reducing exposure rather than initiating new positions. This institutional vacuum suggests today’s breakouts are retail-driven momentum plays vulnerable to rapid reversals. Only EVMN warrants consideration for swing trades, while the remainder serve as cautionary examples of low-quality technical setups in a deteriorating market environment.

Share: